JOHN PARMELEE: Open Payments
NPI 1184733347 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$919 in 52 payments from 15 companies in 2025. Trend: 2023 $1,715 · 2024 $1,076 · 2025 $919
Food & beverage: $919
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 12 | $221 |
| Astellas Pharma US Inc | 6 | $104 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $104 |
| Lilly USA, LLC | 5 | $82 |
| ABBVIE INC. | 4 | $81 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $62 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $52 |
| AstraZeneca Pharmaceuticals LP | 3 | $45 |
| Exact Sciences Corporation | 2 | $35 |
| Abbott Laboratories | 2 | $31 |
Products named: PREVNAR 20, NURTEC ODT, Veozah, Kerendia, JARDIANCE, UBRELVY, XIFAXAN, MOUNJARO.
Industry payments across OK — which companies pay providers there.
